Literature DB >> 3244623

In vivo model for ciclosporin intestinal absorption in lipid vehicles.

J P Reymond1, H Sucker, J Vonderscher.   

Abstract

The influence of lipid vehicles on the intestinal absorption of Ciclosporin was studied in vivo. The model takes into account the effect of the intestinal lipid digestion on the absorption after intraduodenal administration of [3H]Ciclosporin in olive oil or middle-chain triglyceride (MCT) to the bile duct-cannulated rat. Digested vehicles significantly promoted the absorption compared to nondigested vehicles. In the nondigested state, olive oil was a significantly better vehicle than MCT, whereas the difference between both lipids was only a trend in the digested state. Further studies with variants of this in vivo model should determine the influence of abnormalities of fat digestion and absorption on the pharmacokinetics and pharmacodynamics of a drug with a low therapeutical index.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244623     DOI: 10.1023/a:1015939307478

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans.

Authors:  T R Bates; J A Sequeria
Journal:  J Pharm Sci       Date:  1975-05       Impact factor: 3.534

2.  Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.

Authors:  R Venkataramanan; R J Ptachcinski; G J Burckart; S Yang; T E Starzl
Journal:  J Pharm Sci       Date:  1985-08       Impact factor: 3.534

3.  The effect of different oils on the absorption of probucol in the rat.

Authors:  K J Palin; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1984-09       Impact factor: 3.765

4.  The effect of oils on the lymphatic absorption of DDT.

Authors:  K J Palin; C G Wilson; S S Davis; A J Phillips
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

Review 5.  Lipid digestion and absorption.

Authors:  M C Carey; D M Small; C M Bliss
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

6.  Rat lingual lipase. Characteristics of enzyme activity.

Authors:  M Hamosh; D Ganot; P Hamosh
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

7.  In vitro model for ciclosporin intestinal absorption in lipid vehicles.

Authors:  J P Reymond; H Sucker
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

8.  Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats.

Authors:  C T Ueda; M Lemaire; G Gsell; K Nussbaumer
Journal:  Biopharm Drug Dispos       Date:  1983 Apr-Jun       Impact factor: 1.627

Review 9.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

10.  Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback.

Authors:  H J Weis; J M Dietschy
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

  10 in total
  6 in total

1.  Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation.

Authors:  E A Mueller; J M Kovarik; J B van Bree; J Grevel; P W Lücker; K Kutz
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

2.  Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.

Authors:  Verica Risovic; Michael Boyd; Eugene Choo; Kishor M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

3.  Cyclosporin absorption is impaired by the fat substitutes, sucrose polyester and tricarballylate triester, in the rat.

Authors:  K Benmoussa; A Sabouraud; J M Scherrmann; J M Bourre
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

4.  Non-linear increases in danazol exposure with dose in older vs. younger beagle dogs: the potential role of differences in bile salt concentration, thermodynamic activity, and formulation digestion.

Authors:  Mette U Anby; Hywel D Williams; Orlagh Feeney; Glenn A Edwards; Hassan Benameur; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2014-01-30       Impact factor: 4.200

Review 5.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

6.  Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.

Authors:  Ann Marie Kaukonen; Ben J Boyd; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.